Identification of the Ah-Receptor Structural Determinants for Ligand Preferences
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
The aryl hydrocarbon receptor (AHR) is a transcription factor that responds to diverse ligands and plays a critical role in toxicology, immune function, and cardiovascular physiology. The structural basis of the AHR for ligand promiscuity and preferences is critical for understanding AHR function. Based on the structure of a closely related protein HIF2α, we modeled the AHR ligand binding domain (LBD) bound to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and benzo(a)pyrene (BaP) and identified residues that control ligand preferences by shape and H-bond potential. Mutations to these residues, particularly Q377 and G298, resulted in robust and opposite changes in the potency of TCDD and BaP and up to a 20-fold change in the ratio of TCDD/BaP efficacy. The model also revealed a flexible "belt" structure; molecular dynamic (MD) simulation suggested that the "belt" and several other structural elements in the AHR-LBD are more flexible than HIF2α and likely contribute to ligand promiscuity. Molecular docking of TCDD congeners to a model of human AHR-LBD ranks their binding affinity similar to experimental ranking of their toxicity. Our study reveals key structural basis for prediction of toxicity and understanding the AHR signaling through diverse ligands.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“homology models of the AHR ligand-binding domain (LBD) are available for only a few species.”
In the citing paper
“More recent studies have reported that the ligand binding promiscuity of a given AHR may result from differential binding of structurally diverse ligands within the AHR ligand-binding cavity (11-14), similar to the mechanisms responsible for pregnane X receptor ligand binding promiscuity (15,16).”
In the citing paper
“While the lack of any three-dimensional structure information on the AHR ligand binding domain (LBD) has prevented detailed molecular analysis of the mechanisms of AHR ligand binding, we and others have used the availability of crystal and nuclear magnetic resonance (NMR) structures of homologous protein domains to develop homology models of the AHR LBD for such analysis (12,17-20).”
In the citing paper
“These theoretical models not only have revealed key structural aspects of the domain, but when coupled with site directed mutagenesis and functional analysis, have proven to be helpful in identifying amino acids important in ligand binding and ligand-dependent AHR activation (12,17-19,21).”
In the citing paper
“While the binding modes of TCDD and other ligands within the AHR LBD of a given species (typically that of mouse or human AHR) have been predicted by these approaches, experimental confirmation of these proposed interactions are generally lacking.”
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Comparison of simple potential functions for simulating liquid water
Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., & Klein, M. L. (1983) · The Journal of Chemical Physics · doi:10.1063/1.445869 · Cited by 41,298
GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation
Hess, B., Kutzner, C., van der Spoel, D., & Lindahl, E. (2008) · Journal of Chemical Theory and Computation · doi:10.1021/ct700301q · Cited by 15,908
Understanding Molecular Simulation: From Algorithms to Applications
Frenkel, D., Smit, B., & Ratner, M. A. (1997) · Physics Today · doi:10.1063/1.881812 · Cited by 5,059
Van den Berg, M., Birnbaum, L. S., Denison, M., De Vito, M., Farland, W., Feeley, M., Fiedler, H., Hakansson, H., Hanberg, A., Haws, L., et al. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl055 · Cited by 3,785
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Opitz, C. A., Litzenburger, U. M., Sahm, F., Ott, M., Tritschler, I., Trump, S., Schumacher, T., Jestaedt, L., Schrenk, D., Weller, M., et al. (2011) · Nature · doi:10.1038/nature10491 · Cited by 1,898
An Interaction between Kynurenine and the Aryl Hydrocarbon Receptor Can Generate Regulatory T Cells
Mezrich, J. D., Fechner, J. H., Zhang, X., Johnson, B. P., Burlingham, W. J., & Bradfield, C. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903670 · Cited by 1,601
Self-citationAutomated docking of flexible ligands: Applications of autodock
Goodsell, D. S., Morris, G. M., & Olson, A. J. (1996) · Journal of Molecular Recognition · doi:10.1002/(sici)1099-1352(199601)9:1<1::aid-jmr241>3.0.co;2-6 · Cited by 1,582
Poland, A., Glover, E., & Kende, A. S. (1976) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33205-2 · Cited by 1,370 · cited 1×
“Enormous efforts have been devoted to identification of AHR ligands over the past four decades since the striking observation that the AHR mediates the toxicity of 2,3,7,8-tet rachlorodibenzo-p-dioxin (TCDD) (Poland et al., 1976).”
BackgroundINDUCTION OF CYTOCHROME P4501A1
Whitlock, J. P. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.103 · Cited by 1,124
AH RECEPTOR SIGNALING PATHWAYS
Schmidt, J. V., & Bradfield, C. A. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.55 · Cited by 899 · cited 5×
“nuclear translocator” (ARNT) (Schmidt and Bradfield, 1996).”
BackgroundInfluentialSelf-citationExogenous Stimuli Maintain Intraepithelial Lymphocytes via Aryl Hydrocarbon Receptor Activation
Li, Y., Innocentin, S., Withers, D. R., Roberts, N. A., Gallagher, A. R., Grigorieva, E. F., Wilhelm, C., & Veldhoen, M. (2011) · Cell · doi:10.1016/j.cell.2011.09.025 · Cited by 820
Reyes, H., Reisz-Porszasz, S., & Hankinson, O. (1992) · Science · doi:10.1126/science.256.5060.1193 · Cited by 777
Safe, S. H. (1986) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.26.040186.002103 · Cited by 710 · cited 1×
“…to each model was normalized to that of TCDD and then compared to the experimentally determined affinity or toxicity that was also normalized to TCDD. Experimental data on the binding affinity or toxicity of TCDD congeners were summarized from published data sets (Ashek et al., 2006; Safe, 1986).”
MethodThe Search for Endogenous Activators of the Aryl Hydrocarbon Receptor
Nguyen, L. P., & Bradfield, C. A. (2008) · Chemical Research in Toxicology · doi:10.1021/tx7001965 · Cited by 709 · cited 1×
“Thousands of environmental toxins have been suggested to be the AHR ligands and mediate broad physiological responses (Nguyen and Bradfield, 2008; Schmidt and Bradfield, 1996).”
BackgroundSelf-citationAssociation of the Ah receptor with the 90-kDa heat shock protein.
Perdew, G. H. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68314-0 · Cited by 509 · cited 1×
“The unliganded AHR is located in cytosol and associated with protein chaperones (i.e., Hsp90, p23, and AHR-interacting protein 1) (Carver et al., 1998; Kazlauskas et al., 1999; Meyer and Perdew, 1999; Meyer et al., 1998; Perdew, 1988).”
BackgroundThe aryl hydrocarbon receptor in immunity
Esser, C., Rannug, A., & Stockinger, B. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.06.005 · Cited by 447
The aryl hydrocarbon receptor: a perspective on potential roles in the immune system
Stevens, E. A., Mezrich, J. D., & Bradfield, C. A. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03054.x · Cited by 413
Self-citationMeyer, B. K., Pray-Grant, M. G., Vanden Heuvel, J. P., & Perdew, G. H. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.978 · Cited by 386
Ah receptor: Dioxin-mediated toxic responses as hints to deregulated physiologic functions
Bock, K. W., & Köhle, C. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.01.017 · Cited by 337 · cited 1×
“Halogenated aromatic hydrocarbons induce the expression of a battery of proteins that lead to severe toxic endpoints such as chloracne, thymic involution, cleft palate, and cancer (Bock and Köhle, 2006; McMillan and Bradfield, 2007).”
BackgroundDioxin binding activities of polymorphic forms of mouse and human arylhydrocarbon receptors.
Ema, M., Ohe, N., Suzuki, M., Mimura, J., Sogawa, K., Ikawa, S., & Fujii-Kuriyama, Y. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)46990-6 · Cited by 329 · cited 2×
“Ala375, a residue whose genetic variations have a strong effect on the AHR activity (Chang et al., 1993; Ema et al., 1994; Poland et al., 1994), is located between the two H-bond networks and in a close proximity to the ligand medial positions (Fig.”
BackgroundAnalysis of the four alleles of the murine aryl hydrocarbon receptor
Poland, A., Palen, D., & Glover, E. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09833-5 · Cited by 303 · cited 1×
“The D-allele harbors a valine instead of alanine (Supplementary figure S3) and exhibits a reduced binding affinity between the AHR and TCDD (Chang et al., 1993; Ema et al., 1994; Poland et al., 1994).”
BackgroundKazlauskas, A., Poellinger, L., & Pongratz, I. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13519 · Cited by 302 · cited 1×
“The unliganded AHR is located in cytosol and associated with protein chaperones (i.e., Hsp90, p23, and AHR-interacting protein 1) (Carver et al., 1998; Kazlauskas et al., 1999; Meyer and Perdew, 1999; Meyer et al., 1998; Perdew, 1988).”
BackgroundArtificial ligand binding within the HIF2α PAS-B domain of the HIF2 transcription factor
Scheuermann, T. H., Tomchick, D. R., Machius, M., Guo, Y., Bruick, R. K., & Gardner, K. H. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808092106 · Cited by 301 · cited 1×
“Similar to previous modeling of the structure of AHR-LBD, we utilized the crystal structure of HIF2α PAS-B motif (Scheuermann et al., 2009) as an initial model, which shares almost 30% sequence similarity to AHR-LBD (Supplementary figure S1).”
MethodNuclear Localization and Export Signals of the Human Aryl Hydrocarbon Receptor
Ikuta, T., Eguchi, H., Tachibana, T., Yoneda, Y., & Kawajiri, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.2895 · Cited by 287 · cited 1×
“Upon ligand binding, the AHR is translocated to the nucleus (Ikuta et al., 1998; Petrulis et al., 2003), where the liganded AHR forms a heterodimeric complex with the AHR transcription partner, AHR nuclear translocator (ARNT) (Schmidt and Bradfield, 1996).”
BackgroundIn vitro analysis of Ah receptor domains involved in ligand-activated DNA recognition.
Dolwick, K. M., Swanson, H. I., & Bradfield, C. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8566 · Cited by 239 · cited 1×
“For permissions, please email: journals.permissions@oup.com The minimal ligand binding domain (LBD) of the AHR has been mapped to a hydrophobic region encompassing PAS-B and the sequence immediately following PAS-B (Coumailleau et al., 1995; Dolwick et al., 1993).”
BackgroundSelf-citationMeyer, B. K., & Perdew, G. H. (1999) · Biochemistry · doi:10.1021/bi982223w · Cited by 232 · cited 1×
“The unliganded AHR is located in cytosol and associated with protein chaperones (i.e., Hsp90, p23, and AHR-interacting protein 1) (Carver et al., 1998; Kazlauskas et al., 1999; Meyer and Perdew, 1999; Meyer et al., 1998; Perdew, 1988).”
BackgroundCharacterization of the Ah Receptor-associated Protein, ARA9
Carver, L. A., LaPres, J. J., Jain, S., Dunham, E. E., & Bradfield, C. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.50.33580 · Cited by 208 · cited 1×
“The unliganded AHR is located in cytosol and associated with protein chaperones (i.e., Hsp90, p23, and AHR-interacting protein 1) (Carver et al., 1998; Kazlauskas et al., 1999; Meyer and Perdew, 1999; Meyer et al., 1998; Perdew, 1988).”
BackgroundSelf-citationThe Aryl Hydrocarbon Receptor sans Xenobiotics: Endogenous Function in Genetic Model Systems
McMillan, B. J., & Bradfield, C. A. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.037259 · Cited by 177 · cited 1×
“Halogenated aromatic hydrocarbons induce the expression of a battery of proteins that lead to severe toxic endpoints such as chloracne, thymic involution, cleft palate, and cancer (Bock and Köhle, 2006; McMillan and Bradfield, 2007).”
BackgroundSelf-citationThe Zebrafish (Danio rerio) Aryl Hydrocarbon Receptor Type 1 Is a Novel Vertebrate Receptor
Andreasen, E. A., Hahn, M. E., Heideman, W., Peterson, R. E., & Tanguay, R. L. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.2.234 · Cited by 175 · cited 1×
“A nonresponsive Ahr allele identified in zebrafish (drAHR1a) (Andreasen et al., 2002) also harbors a genetic variation for this residue, A375T (Supplementary figure S3), which would weaken ligand binding similar to A375V.”
BackgroundThe Role of Aryl Hydrocarbon Receptor in the Pathogenesis of Cardiovascular Diseases
Korashy, H. M., & El-Kadi, A. O. S. (2006) · Drug Metabolism Reviews · doi:10.1080/03602530600632063 · Cited by 173 · cited 1×
“The AHR is also found to be essential for the normal function of the vascular and immune systems (Esser et al., 2009; Korashy and El-Kadi, 2006; Savouret et al., 2003; Stevens et al., 2009), presumably through activation by unknown endogenous ligands.”
BackgroundCoumailleau, P., Poellinger, L., Gustafsson, J.-Å., & Whitelaw, M. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.25291 · Cited by 172 · cited 5×
“The AHR harbors an internal PAS domain with two degenerate repeats known as PAS-A and PAS-B (Coumailleau et al., 1995; Dolwick et al., 1993).”
BackgroundInfluentialPandini, A., Denison, M. S., Song, Y., Soshilov, A. A., & Bonati, L. (2007) · Biochemistry · doi:10.1021/bi061460t · Cited by 160 · cited 2×
“Two hydrophobic residues within the “belt”, F318 and I319, are predicted to directly contact the ligand (Supplementary figure S2A), among which F318 was previously shown to be important for ligand binding (Pandini et al., 2007; Pandini et al., 2009).”
BackgroundBisson, W. H., Koch, D. C., O’Donnell, E. F., Khalil, S. M., Kerkvliet, N. I., Tanguay, R. L., Abagyan, R., & Kolluri, S. K. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900199u · Cited by 149 · cited 1×
“The structure of the AHR-LBD had been modeled by different groups (Bisson et al., 2009; Pandini et al., 2009; Procopio et al., 2002).”
MethodPetrulis, J. R., Kusnadi, A., Ramadoss, P., Hollingshead, B., & Perdew, G. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209331200 · Cited by 129 · cited 1×
“Upon ligand binding, the AHR is translocated to the nucleus (Ikuta et al., 1998; Petrulis et al., 2003), where the liganded AHR forms a heterodimeric complex with the AHR transcription partner, AHR nuclear translocator (ARNT) (Schmidt and Bradfield, 1996).”
BackgroundPandini, A., Soshilov, A. A., Song, Y., Zhao, J., Bonati, L., & Denison, M. S. (2009) · Biochemistry · doi:10.1021/bi900259z · Cited by 124 · cited 3×
“The structure of the AHR-LBD had been modeled by different groups (Bisson et al., 2009; Pandini et al., 2009; Procopio et al., 2002).”
BackgroundMethodComparison of recombinant cell bioassays for the detection of Ah receptor agonists
Han, D., Nagy, S. R., & Denison, M. S. (2004) · BioFactors · doi:10.1002/biof.5520200102 · Cited by 114 · cited 1×
“DREs-driven luciferase reporter vector (100 ng) (Han et al., 2004) and TK-renilla luciferase”
BackgroundChang, C.-Y., Smith, D. R., Prasad, V. S., Sidman, C. L., Nebert, D. W., & Puga, A. (1993) · Pharmacogenetics · doi:10.1097/00008571-199312000-00005 · Cited by 103 · cited 1×
“Ala375, a residue whose genetic variations have a strong effect on the AHR activity (Chang et al., 1993; Ema et al., 1994; Poland et al., 1994), is located between the two H-bond networks and in a close proximity to the ligand medial positions (Fig.”
BackgroundArulmozhiraja, S., & Morita, M. (2004) · Chemical Research in Toxicology · doi:10.1021/tx0300380 · Cited by 72 · cited 2×
“This mode of ligand binding is consistent with the previous observation that the medial extension of the AHR ligand reduces ligand binding affinity (Ashek et al., 2006) and that addition of bulky groups to the lateral positions of the ligand favors AHR binding (Arulmozhiraja and Morita, 2004).”
BackgroundMethodSavouret, J., Berdeaux, A., & Casper, R. F. (2003) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/s0939-4753(03)80026-1 · Cited by 68
A model for recognition of polychlorinated dibenzo‐p‐dioxins by the aryl hydrocarbon receptor
Procopio, M., Lahm, A., Tramontano, A., Bonati, L., & Pitea, D. (2002) · European Journal of Biochemistry · doi:10.1046/j.0014-2956.2002.02619.x · Cited by 61 · cited 2×
“The structure of the AHR-LBD had been modeled by different groups (Bisson et al., 2009; Pandini et al., 2009; Procopio et al., 2002).”
MethodChan, W. K., Chu, R., Jain, S., Reddy, J. K., & Bradfield, C. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47217-1 · Cited by 48
Self-citationHepatic Transcriptional Networks Induced by Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin
Hayes, K. R., Zastrow, G. M., Nukaya, M., Pande, K., Glover, E., Maufort, J. P., Liss, A. L., Liu, Y., Moran, S. M., Vollrath, A. L., et al. (2007) · Chemical Research in Toxicology · doi:10.1021/tx7003294 · Cited by 36 · cited 2×
“that mediates toxin metabolism and adaptive response (Hayes et al., 2007; Whitlock, 1999).”
BackgroundSelf-citation3D QSAR studies of dioxins and dioxin-like compounds using CoMFA and CoMSIA
Ashek, A., Lee, C., Park, H., & Cho, S. J. (2006) · Chemosphere · doi:10.1016/j.chemosphere.2006.01.010 · Cited by 31 · cited 1×
“This mode of ligand binding is consistent with the previous observation that the medial extension of the AHR ligand reduces ligand binding affinity (Ashek et al., 2006) and that addition of bulky groups to the lateral positions of the ligand favors AHR binding (Arulmozhiraja and Morita, 2004).”
BackgroundJogalekar, A. S., Reiling, S., & Vaz, R. J. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.09.019 · Cited by 23
Food for thought … on education in alternative methods in toxicology
Härtung, T., Blaauboer, B., & Leist, M. (2009) · ALTEX · doi:10.14573/altex.2009.4.255 · Cited by 20
Research works printed but not linked: 1
- Frenkel, (1996)., Understanding Molecular Simulations: From Algorithms to Applications
Cited by
Trace derivatives of kynurenine potently activate the aryl hydrocarbon receptor (AHR)
Seok, S.-H., Ma, Z.-X., Feltenberger, J. B., Chen, H., Chen, H., Scarlett, C., Lin, Z., Satyshur, K. A., Cortopassi, M., Jefcoate, C. R., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000631 · Cited by 157
“This replacement increases the steric hindrance to the medial positions of ligands (19), particularly environmental ligands that are bulkier in the medial direction, such as BaP, which could barely stimulate the activity of the A375V D-allele (Fig.”
BackgroundMethodInfluentialSelf-citationThe Ah Receptor: Adaptive Metabolism, Ligand Diversity, and the Xenokine Model
Avilla, M. N., Malecki, K. M. C., Hahn, M. E., Wilson, R. H., & Bradfield, C. A. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00476 · Cited by 158
Self-citationAryl Hydrocarbon Receptor (AHR) Ligands as Selective AHR Modulators (SAhRMs)
Safe, S. H., Jin, U.-H., Park, H., Chapkin, R. S., & Jayaraman, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186654 · Cited by 148
Seok, S.-H., Lee, W., Jiang, L., Molugu, K., Zheng, A., Li, Y., Park, S., Bradfield, C. A., & Xing, Y. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617035114 · Cited by 127
“Discussion The ability of the AHR to respond to diverse environmental and cellular ligands is believed to primarily reside in the ligand-binding PAS-B domain of AHR, which possesses distinct structural determinants and flexibility for controlling ligand-binding promiscuity and specificity (38).”
BackgroundSelf-citationModeling the binding of diverse ligands within the Ah receptor ligand binding domain
Giani Tagliabue, S., Faber, S. C., Motta, S., Denison, M. S., & Bonati, L. (2019) · Scientific Reports · doi:10.1038/s41598-019-47138-z · Cited by 106
Metadata
- Authors
- Xing, Y., Nukaya, M., Satyshur, K. A., Jiang, L., Stanevich, V., Korkmaz, E. N., Burdette, L., Kennedy, G. D., Cui, Q., & Bradfield, C. A.
- Affiliations
- University of Wisconsin System (US)
- University of Wisconsin–Madison (US)
- Corresponding author
- Xing, Yongna
- ORCID
- Venue
- Toxicological Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-06-02
- Volume
- 129
- Issue
- 1
- Pages
- 86-97
- ISSN
- 1096-0929 (ISSN-L)
- 1096-6080
- PMC
- PMC3491955
- OpenAlex
- W2118382882
- Cited by
- 67
- References
- 45
- Citations by year
- 2026: 3 · 2024: 1 · 2023: 4 · 2022: 8 · 2021: 5 · 2020: 8 · 2019: 7 · 2018: 5 · 2017: 7 · 2016: 7 · 2015: 3 · 2014: 4 · 2013: 4 · 2012: 1
- FWCI
- 2.66
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Toxicological Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (2r56ai063325-06a1)
- National Cancer Institute (P30CA014520)
- National Institute of General Medical Sciences (R01GM096060)
- National Institute of Allergy and Infectious Diseases (2R56AI063325-06A1)
- National Institute of Environmental Health Sciences (R01ES020668, K08ES017283)
- Topics
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Toxic Organic Pollutants Impact
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Keywords
- aryl hydrocarbon receptor, ligand-binding domain, ligand promiscuity, 2,3,7,8-tetrachlorodibenzo-p-dioxin, benzo[a]pyrene, HIF-2α, structural factors, protein flexibility, toxicity prediction, molecular docking, molecular dynamics simulation
- MeSH terms
- Polychlorinated Dibenzodioxins, Amino Acid Sequence, Benzo(a)pyrene, Ligands, Models, Molecular, Molecular Sequence Data, Mutation, Protein Conformation, Receptors, Aryl Hydrocarbon, Molecular Dynamics Simulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.